A Super Bowl Ad Sparks Controversy and Signals a New Era in U.S. Health
Hims and Hers is airing an ad about its copycat GLP-1 drugs during Sunday’s Super Bowl. Critics say it violates FDA rules.
WPEC West Palm Beach on MSN12h
The battle over anti-obesity medications
The new class of anti-obesity medications has become some of the most sought-after prescription drugs in history. According ...
Weight Loss Drug Super Bowl Ad Raises Questions About Compounded Vs. Branded Meds
An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use ...
BioSpace17h
After Unforced Error, Novo Execs Try to Boost CagriSema Sentiment—Without Hard Numbers
Novo Nordisk shares tumbled last year when obesity candidate CagriSema failed to clear a weight loss bar of 25%. Now, ...